Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study has public registry information. It focuses on depression and currently lists study information in the United Kingdom.
In United Kingdom
This study is completed. It focuses on depression and currently lists study information in the United Kingdom.
In United KingdomThis study is completed. It focuses on PTSD and currently lists study information in the United Kingdom.
In United KingdomThis study is completed. It focuses on ADHD and currently lists study information in the United Kingdom.
In United Kingdom
This study is completed. It focuses on schizophrenia and currently lists study information in Germany, Italy, Portugal, Spain, and the United Kingdom.
In United KingdomThis study is completed. It focuses on bipolarity and currently lists study information in the United Kingdom.
In United KingdomThis study is completed. It focuses on PTSD and currently lists study information in Czech Republic, Germany, the Netherlands, Norway, and the United Kingdom.
In United KingdomThis study has public registry information. It focuses on bipolarity and currently lists study information in the United Kingdom.
In United KingdomThis study is ongoing in the United Kingdom. It focuses on treatment-resistant depression.
In United KingdomThis study is completed. It focuses on schizophrenia and currently lists study information in Canada, Israel, Singapore, the United Kingdom, and the United States.
In United KingdomThis study was terminated in the United Kingdom, in Germany, and in the Netherlands. It is testing Phase 2 Clinical Trial of GH001 for Bipolarity.
In United KingdomThis study is completed in the United Kingdom. It focuses on ADHD.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.